Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233
Income Statement
Earnings Waterfall
Shandong Jincheng Pharmaceutical Group Co Ltd
Revenue
|
3.5B
CNY
|
Cost of Revenue
|
-2B
CNY
|
Gross Profit
|
1.5B
CNY
|
Operating Expenses
|
-1.3B
CNY
|
Operating Income
|
237.2m
CNY
|
Other Expenses
|
-62.5m
CNY
|
Net Income
|
174.7m
CNY
|
Income Statement
Shandong Jincheng Pharmaceutical Group Co Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
909
N/A
|
935
+3%
|
974
+4%
|
1 023
+5%
|
1 051
+3%
|
1 091
+4%
|
1 142
+5%
|
1 146
+0%
|
1 179
+3%
|
1 156
-2%
|
1 104
-4%
|
1 133
+3%
|
1 420
+25%
|
1 740
+22%
|
2 115
+22%
|
2 483
+17%
|
2 788
+12%
|
3 043
+9%
|
3 087
+1%
|
3 082
0%
|
3 008
-2%
|
2 815
-6%
|
2 780
-1%
|
2 810
+1%
|
2 795
-1%
|
2 811
+1%
|
2 786
-1%
|
2 767
-1%
|
2 962
+7%
|
2 920
-1%
|
2 984
+2%
|
3 121
+5%
|
3 138
+1%
|
3 483
+11%
|
3 695
+6%
|
3 634
-2%
|
3 506
-4%
|
3 382
-4%
|
3 359
-1%
|
3 483
+4%
|
3 538
+2%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(633)
|
(637)
|
(652)
|
(671)
|
(683)
|
(718)
|
(747)
|
(751)
|
(764)
|
(764)
|
(735)
|
(772)
|
(1 026)
|
(1 293)
|
(1 550)
|
(1 770)
|
(1 796)
|
(1 899)
|
(1 845)
|
(1 726)
|
(1 510)
|
(1 338)
|
(1 209)
|
(1 202)
|
(1 175)
|
(1 225)
|
(1 232)
|
(1 173)
|
(1 249)
|
(1 233)
|
(1 291)
|
(1 439)
|
(1 513)
|
(1 792)
|
(1 969)
|
(1 936)
|
(1 899)
|
(1 852)
|
(1 862)
|
(2 025)
|
(2 037)
|
|
Gross Profit |
276
N/A
|
298
+8%
|
322
+8%
|
352
+9%
|
368
+5%
|
373
+1%
|
394
+6%
|
394
+0%
|
415
+5%
|
393
-5%
|
370
-6%
|
360
-2%
|
395
+10%
|
447
+13%
|
565
+27%
|
713
+26%
|
992
+39%
|
1 144
+15%
|
1 241
+9%
|
1 356
+9%
|
1 498
+10%
|
1 477
-1%
|
1 571
+6%
|
1 607
+2%
|
1 620
+1%
|
1 586
-2%
|
1 554
-2%
|
1 595
+3%
|
1 713
+7%
|
1 687
-1%
|
1 693
+0%
|
1 681
-1%
|
1 625
-3%
|
1 691
+4%
|
1 726
+2%
|
1 699
-2%
|
1 606
-5%
|
1 530
-5%
|
1 497
-2%
|
1 458
-3%
|
1 501
+3%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(176)
|
(190)
|
(199)
|
(216)
|
(228)
|
(218)
|
(223)
|
(219)
|
(237)
|
(240)
|
(241)
|
(246)
|
(247)
|
(270)
|
(329)
|
(436)
|
(635)
|
(755)
|
(847)
|
(925)
|
(1 007)
|
(1 087)
|
(1 129)
|
(1 168)
|
(1 170)
|
(1 427)
|
(1 450)
|
(1 527)
|
(1 361)
|
(2 129)
|
(2 161)
|
(2 171)
|
(1 371)
|
(1 390)
|
(1 356)
|
(1 316)
|
(1 217)
|
(1 236)
|
(1 269)
|
(1 244)
|
(1 264)
|
|
Selling, General & Administrative |
(171)
|
(186)
|
(195)
|
(212)
|
(162)
|
(217)
|
(219)
|
(215)
|
(154)
|
(220)
|
(221)
|
(225)
|
(163)
|
(266)
|
(327)
|
(384)
|
(440)
|
(699)
|
(792)
|
(864)
|
(727)
|
(752)
|
(738)
|
(762)
|
(838)
|
(917)
|
(958)
|
(1 073)
|
(1 102)
|
(1 205)
|
(1 247)
|
(1 261)
|
(1 134)
|
(1 176)
|
(1 146)
|
(1 106)
|
(976)
|
(1 060)
|
(1 068)
|
(1 017)
|
(1 023)
|
|
Research & Development |
0
|
0
|
0
|
0
|
(50)
|
0
|
0
|
0
|
(61)
|
0
|
0
|
0
|
(59)
|
0
|
0
|
(49)
|
(139)
|
0
|
0
|
(55)
|
(207)
|
(191)
|
(251)
|
(262)
|
(253)
|
(230)
|
(212)
|
(180)
|
(182)
|
(209)
|
(199)
|
(203)
|
(167)
|
(181)
|
(179)
|
(172)
|
(160)
|
(156)
|
(173)
|
(187)
|
(171)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(23)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(63)
|
0
|
0
|
0
|
(88)
|
0
|
0
|
0
|
(102)
|
0
|
0
|
0
|
(101)
|
0
|
0
|
0
|
(104)
|
0
|
0
|
0
|
(99)
|
0
|
0
|
0
|
(103)
|
|
Other Operating Expenses |
(5)
|
(5)
|
(4)
|
(4)
|
(0)
|
(1)
|
(4)
|
(4)
|
(0)
|
(20)
|
(20)
|
(21)
|
(0)
|
(5)
|
(2)
|
(3)
|
7
|
(56)
|
(55)
|
(5)
|
15
|
(144)
|
(140)
|
(144)
|
23
|
(281)
|
(280)
|
(274)
|
24
|
(715)
|
(714)
|
(707)
|
35
|
(33)
|
(31)
|
(38)
|
18
|
(20)
|
(29)
|
(40)
|
33
|
|
Operating Income |
100
N/A
|
108
+8%
|
123
+14%
|
136
+11%
|
140
+3%
|
155
+11%
|
171
+10%
|
175
+2%
|
178
+1%
|
153
-14%
|
129
-16%
|
115
-11%
|
148
+29%
|
177
+20%
|
236
+34%
|
277
+17%
|
357
+29%
|
389
+9%
|
395
+1%
|
431
+9%
|
490
+14%
|
390
-21%
|
442
+13%
|
439
-1%
|
451
+3%
|
159
-65%
|
104
-34%
|
68
-35%
|
352
+416%
|
(441)
N/A
|
(468)
-6%
|
(490)
-5%
|
254
N/A
|
301
+18%
|
370
+23%
|
382
+3%
|
390
+2%
|
294
-24%
|
227
-23%
|
215
-6%
|
237
+10%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(17)
|
(16)
|
(13)
|
(12)
|
(12)
|
(9)
|
(9)
|
(0)
|
4
|
2
|
5
|
(2)
|
3
|
2
|
(4)
|
(8)
|
(17)
|
(22)
|
(9)
|
4
|
5
|
5
|
(1)
|
(2)
|
(6)
|
3
|
(3)
|
(21)
|
(25)
|
(29)
|
(27)
|
(17)
|
(14)
|
(15)
|
(12)
|
(11)
|
(10)
|
(18)
|
(18)
|
(19)
|
(8)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(3)
|
4
|
0
|
4
|
(2)
|
1
|
1
|
1
|
(129)
|
(0)
|
(0)
|
0
|
(294)
|
0
|
0
|
0
|
(741)
|
0
|
1
|
1
|
(31)
|
2
|
5
|
5
|
(32)
|
1
|
(6)
|
(5)
|
(5)
|
|
Gain/Loss on Disposition of Assets |
0
|
(0)
|
(7)
|
0
|
(9)
|
(16)
|
(10)
|
(10)
|
(3)
|
(3)
|
(2)
|
(3)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(3)
|
(3)
|
2
|
(5)
|
5
|
13
|
13
|
18
|
11
|
23
|
23
|
21
|
22
|
5
|
6
|
3
|
4
|
(2)
|
(2)
|
(3)
|
4
|
2
|
137
|
161
|
164
|
157
|
19
|
(7)
|
(6)
|
(9)
|
(9)
|
(9)
|
(13)
|
(13)
|
(22)
|
(20)
|
(1)
|
(5)
|
5
|
4
|
1
|
|
Pre-Tax Income |
80
N/A
|
89
+11%
|
104
+17%
|
118
+14%
|
123
+4%
|
143
+16%
|
165
+16%
|
183
+11%
|
173
-6%
|
175
+1%
|
154
-12%
|
132
-15%
|
170
+29%
|
188
+11%
|
238
+27%
|
276
+16%
|
341
+24%
|
366
+7%
|
384
+5%
|
433
+13%
|
370
-14%
|
396
+7%
|
578
+46%
|
598
+3%
|
315
-47%
|
319
+1%
|
120
-62%
|
41
-66%
|
(425)
N/A
|
(479)
-13%
|
(502)
-5%
|
(515)
-2%
|
197
N/A
|
274
+39%
|
341
+24%
|
355
+4%
|
346
-3%
|
272
-21%
|
209
-23%
|
194
-7%
|
225
+16%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(16)
|
(19)
|
(15)
|
(19)
|
(15)
|
(16)
|
(24)
|
(23)
|
(4)
|
(5)
|
1
|
5
|
(14)
|
(14)
|
(23)
|
(31)
|
(51)
|
(60)
|
(67)
|
(79)
|
(88)
|
(88)
|
(121)
|
(119)
|
(101)
|
(103)
|
(66)
|
(58)
|
(55)
|
(50)
|
(53)
|
(49)
|
(73)
|
(88)
|
(92)
|
(95)
|
(60)
|
(47)
|
(36)
|
(28)
|
(32)
|
|
Income from Continuing Operations |
65
|
71
|
90
|
100
|
109
|
127
|
142
|
160
|
169
|
170
|
155
|
137
|
156
|
174
|
215
|
244
|
290
|
307
|
318
|
354
|
282
|
308
|
457
|
479
|
214
|
216
|
54
|
(17)
|
(481)
|
(529)
|
(555)
|
(564)
|
123
|
186
|
249
|
260
|
286
|
225
|
172
|
165
|
193
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
5
|
3
|
(1)
|
(5)
|
(7)
|
(4)
|
(2)
|
(4)
|
(10)
|
(19)
|
(19)
|
(20)
|
(15)
|
(11)
|
(10)
|
(7)
|
(7)
|
(8)
|
(10)
|
(10)
|
(13)
|
(15)
|
(17)
|
(15)
|
(14)
|
(13)
|
(14)
|
(16)
|
(18)
|
(19)
|
|
Net Income (Common) |
65
N/A
|
71
+9%
|
90
+27%
|
100
+12%
|
109
+9%
|
127
+17%
|
142
+12%
|
160
+13%
|
171
+7%
|
174
+1%
|
159
-8%
|
142
-11%
|
159
+12%
|
173
+8%
|
210
+21%
|
238
+13%
|
286
+20%
|
304
+6%
|
313
+3%
|
345
+10%
|
264
-23%
|
290
+10%
|
437
+51%
|
464
+6%
|
203
-56%
|
206
+1%
|
47
-77%
|
(24)
N/A
|
(489)
-1 937%
|
(539)
-10%
|
(565)
-5%
|
(576)
-2%
|
108
N/A
|
170
+57%
|
234
+38%
|
246
+5%
|
273
+11%
|
211
-23%
|
156
-26%
|
147
-6%
|
175
+18%
|
|
EPS (Diluted) |
0.27
N/A
|
0.29
+7%
|
0.37
+28%
|
0.41
+11%
|
0.43
+5%
|
0.51
+19%
|
0.56
+10%
|
0.63
+13%
|
0.68
+8%
|
0.68
N/A
|
0.62
-9%
|
0.55
-11%
|
0.63
+15%
|
0.57
-10%
|
0.53
-7%
|
0.6
+13%
|
0.77
+28%
|
0.77
N/A
|
0.79
+3%
|
0.87
+10%
|
0.67
-23%
|
0.73
+9%
|
1.11
+52%
|
1.18
+6%
|
0.52
-56%
|
0.53
+2%
|
0.12
-77%
|
-0.06
N/A
|
-1.26
-2 000%
|
-1.37
-9%
|
-1.45
-6%
|
-1.63
-12%
|
0.28
N/A
|
0.45
+61%
|
0.62
+38%
|
0.64
+3%
|
0.71
+11%
|
0.55
-23%
|
0.4
-27%
|
0.38
-5%
|
0.45
+18%
|